Status:
COMPLETED
Healing of Rectal Anastomosis Sealed With a Concentrate Derived From the Patient's Blood, After Rectal Cancer Surgery
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Danish Cancer Society
Conditions:
Anastomotic Leak Rectum
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Rectal cancer is one of the most frequent cancer diseases, with more than 1500 new cases per year in Denmark. Fortunately, if the tumor is discovered early, surgeons can remove the part of the intesti...
Eligibility Criteria
Inclusion
- Primary rectal cancer (adenocarcinoma) with the lower boarder within 15 cm from the anal verge assessed by rigid proctoscopy
- Clinical UICC stage I-III at time of rectal cancer diagnosis
- Deemed suitable for intended curative rectal cancer resection at MDT either by total mesorectal excision (TME) or partial mesorectal excision (PME)
- Scheduled for elective, minimal invasive surgery
- ECOG performance status 0-2
- Age at least 18 years
- Written and orally informed consent
Exclusion
- Distant metastatic disease
- Locally advanced rectal cancer requiring extended resection
- Open surgery
- Benign lesions of the rectum
- Inflammatory bowel disease
- Another malignant disease within previous 2 years
- Inability and unwillingness to give informed consent
- Pregnant (positive pregnancy test) or breast feeding women
Key Trial Info
Start Date :
December 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 8 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05293054
Start Date
December 15 2021
End Date
November 8 2023
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Aarhus University Hospital
Aarhus, Central Jutland, Denmark, 8200